Why the study?
Does the DOAC Dipstick test accurately detect the presence or absence of DOACs in urine for rapid medical decision-making?
Does the DOAC Dipstick test accurately detect the presence or absence of DOACs in urine for rapid medical decision-making?
The DOAC Dipstick provides a rapid, point-of-care method to detect DOACs in urine, aiding urgent medical decision-making in emergencies.
Answers are grounded in this paper and cite their sources.
No study data on DOAC Dipstick; leaves accuracy for rapid decisions unresolved.
The assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) can be important for rapid medical decision-making, especially in patients needing immediate management. An assay that screens for the absence or presence of a DOAC would help accelerate treatment in these situations. Chromogenic and coagulation methods have several limitations, including limited accuracy, long turnaround time, and their need of specialized laboratories. Oral factor Xa and thrombin inhibitors are also eliminated by the kidneys and can be detected in patient urine samples using a single, rapid, sensitive, and patient-specific qualitative assay. In these tests, the presence or absence of a DOAC in urine can be identified by visually observing specific colors after a few minutes. Several studies have demonstrated the robustness and repeatability of these assays. The specific colors of the test strip also detect creatinine in the urine, which shows whether DOAC excretion is reduced, thus suggesting renal impairment. Persons with amblyopia may use a specific reader. Current indications for using the DOAC Dipstick test include emergency medical situations with severe bleeding and thrombotic events or before urgent major surgical interventions to accelerate medical decision-making.
No takes yet. Share an insight, caveat, or question.
Harenberg et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: